Financings in Brief: Cardiac Pathways
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Pathways: Commences initial public offering of 2.5 mil. shares at a price of $19 per share. The offering was priced considerably higher than the $12 per share projected by the cardiac ablation products manufacturer in its April SEC filing ("The Gray Sheet" April 22, I&W-17)...